Top 5 Contagion® News Articles for the Week of November 19, 2017
NOV 25, 2017 | CONTAGION® EDITORIAL STAFF
#5: Drug-Resistant Strains of Gonorrhea Spreads to North America
The incidence of drug-resistant gonorrhea infections has grown in the past several years; however, the majority of these infections have been reported outside of North America. Until now. According to a recent dispatch from the Centers for Disease Control and Prevention (CDC), a drug-resistant strain of Neisseria gonorrhoeae (N. gonorrhoeae ) was found in Canada this year.
As Contagion® reported in July 2017, gonorrhea, a sexually-transmitted disease caused by N. gonorrhoeae bacteria, is on its way to becoming untreatable. According to the World Health Organization (WHO) Global Gonococcal Antimicrobial Surveillance Programme (WHO GASP), an estimated 78 million individuals are infected with gonorrhea on an annual basis, and the number of cases that are resistant to currently available antibiotics continues to grow. Teodora Wi, MD, Medical Officer, Human Reproduction at WHO, explained in a news release, “The bacteria that cause gonorrhea are particularly smart. Every time we use a new class of antibiotics to treat the infection, the bacteria evolve to resist them.”
Read more about antibiotic-resistant gonorrhea here.
#4: No Benefits for Protease Inhibitor Plus Raltegravir As Second Line HIV
A recent study showed that treatment with a protease inhibitor plus raltegravir offered no benefit over a protease inhibitor plus nucleoside reverse-transcriptase inhibitor (NRTI) regimen in patients with HIV.
James G. Hakim, MD, from the University of Zimbabwe Clinical Research Centre, Harare, and colleagues published the results of their study November 3, 2017, in the Lancet Infectious Diseases.
We break down our top HIV news stories of 2017. Did you read them all?
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512